San Francisco, 27 March,
Genomics Market Size, Share & Trends Analysis Report By Deliverables, By
Application & Technology (Functional Genomics, Epigenomics), By End Use
(Pharma & Biotech Companies), And Segment Forecasts, 2019 – 2025.
The global genomics market size is expected to reach USD 27.6 billion by 2025,
according to a new report by Grand View Research, Inc. The market is projected
to expand at a CAGR of 9.1% over the forecast period. The past decades have
witnessed significant changes in disease management processes due to
simultaneous advancements in genomics and personalized medicine. There has been
a gradual growth in the usage of genomic studies in clinical practices, which
is reflected by the rising trend of targeted therapies.
Results from genomic studies
enable a better understanding of diseases and the underlying mechanisms for
researchers, physicians, and patients. This facilitates evidence-based
decision-making, and hence, helps improve personalized treatment regime. In
addition, technological advancements in data analysis tools have motivated
healthcare community to create precision-based therapies from surplus,
available DNA data.
One of the most important
factors, which are likely to have a significant impact on the market, is that
how much and to what extent the medical community will make the use of
available genomic information in personalized medicine. Furthermore, plummeting
cost of sequencing has enabled the whole genome sequencing at very less price.
Scientists are combining the sequencing generated data with diagnostics, which
has proven its effectiveness in enhancing personalized treatment landscape.
The companies are involved in
strategic alliances with global, as well as local, entities to boost their
revenue generation and enhance their share in the market. For instance, in
March 2017, Foundation Medicine collaborated with Bristol-Myers Squibb Company.
This enabled Bristol-Myers Squibb to deploy Foundation Medicine’s molecular
information solutions and comprehensive genomic profiling for identification of
predictive biomarkers, such as Microsatellite Instability (MSI) and Tumor
Mutational Burden (TMB), to accelerate its immunotherapy clinical trials.
Access Full Research Report
On Genomics
Market Analysis:
Further key findings from the study suggest:
·
Growing interest of pharma and
biotech companies in genomics is expected to drive the genomics market in
coming years
·
NGS-based services held a major
share of the market due to its rapid adoption in whole genome sequencing and
application of sequence databases for disease screening and prognosis
·
The demand for these services
would remain strong due to growing customer base from academic and research
centers to CROs and biotech and pharma companies
·
Use of predictive biomarkers
for diagnosis and monitoring takes cancer eradication a step further
·
Moreover, various organizations
and programs are actively participating in the development of novel biomarkers
for cancer diagnosis
·
With the rising health
consciousness Direct-To-Consumer (DTC) laboratory testing is increasingly being
employed. Such genetic tests enable consumers to access information about their
genetics without having to visit healthcare professionals
·
Asia Pacific is the potential
regional market for genomics. It is anticipated to expand at the highest CAGR
of 11.2%
·
Major companies in the market
include Beijing Genomics Institute (BGI); Agilent Technologies; Thermo Fisher
Scientific, Inc.; Bio-Rad Laboratories, Inc.; Foundation Medicine, Inc.;
23andMe, Inc.; Danaher, Illumina, Inc.; Pacific Biosciences; Oxford Nanopore
Technologies; F. Hoffmann-La Roche Ltd.; and Myriad Genetics, Inc.
Browse More Reports Of This Category By
Grand View Research At: https://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the
global genomics market on the basis of deliverables, application &
technology, end use, and region:
Genomics Deliverables
Outlook (Revenue, USD Million, 2014 - 2025)
·
Products
o
Instruments/Systems
o
Consumables/Reagents
·
Services
o
Core Genomics Services
o
NGS-based Services
o
Biomarker Translation Services
o
Computational Services
o
Others
Genomics Application &
Technology Outlook (Revenue, USD Million, 2014 - 2025)
·
Functional Genomics
o
Transfection
o
Real-time PCR
o
RNA Interference
o
Mutational Analysis
o
SNP Analysis
o
Microarray Analysis
·
Epigenomics
o
Bisulfite Sequencing
o
Chromatin Immunoprecipitation
(ChIP-Seq)
o
Methylated DNA
Immunoprecipitation (MeDIP)
o
High Resolution Melt (HRM)
o
Chromatin Accessibility Assays
o
Microarray Analysis
·
Pathway Analysis
o
Bead-based Analysis
o
Microarray Analysis
o
Real-time PCR
·
Proteomics Tools (2-D PAGE;
yeast 2-hybrid studies)
o
Biomarker Discovery
o
Mass Spectrometry
o
Real-time PCR
o
Microarray Analysis
o
Statistical Analysis
o
Bioinformatics
o
DNA Sequencing
·
Others
Genomics End-use Outlook
(Revenue, USD Million, 2014 - 2025)
·
Clinical Research
·
Academic and Government
Institutes
·
Hospitals and Clinics
·
Pharmaceutical and
Biotechnology Companies
·
Other End Users
Genomics Regional Outlook
(Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
·
Middle East and Africa (MEA)
o
South Africa
Access Full Press Release of this Report: https://www.grandviewresearch.com/press-release/genomics-market-analysis
About Grand View Research
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment